Skip to content

SCP vs HUSLS for Pelvic Organ Prolapse Repair

Robotic Sacrocolpopexy Versus High Uterosacral Ligament Suspension: A Randomized Trial

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02800512
Enrollment
116
Registered
2016-06-15
Start date
2016-12-27
Completion date
2026-06-10
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystocele, Enterocele, Pelvic Organ Prolapse, Rectocele

Keywords

pelvic organ prolapse, cystocele, rectocele, enterocele

Brief summary

The purpose of this study is to compare the effectiveness of R-SCP versus HUSLS for treatment of pelvic organ prolapse.

Detailed description

To compare the effectiveness of Robotic Sacrocolpopexy versus vaginal High Uterosacral Ligament Suspension for treatment of pelvic organ prolapse. Both surgeries are standard of care and are equally and widely used throughout the country with well known safety and efficacy.

Interventions

PROCEDURERobotic sacrocolpopexy

Sacrocolpopexy is a procedure to surgically correct vaginal vault prolapse where mesh is used to hold the vagina in the correct anatomical position. Robotic assistance is a minimally invasive method to perform this abdominal procedure.

Utilizing uterosacral ligaments to support the vaginal cuff can be performed vaginally-by passing sutures bilaterally through the uterosacral ligaments. near the level of the ischial spine. HUSLS is a vaginal minimally invasive procedure for POP.

Sponsors

Loma Linda University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* 18 Years of age or older * Signed Informed Consent * Symptomatic pelvic organ prolapse, * Willing and able to complete all study visit

Exclusion criteria

* Non-High Uterosacral Ligament Suspension (unable to do HUSLS at time of surgery), * Dementia or considered unable to complete questionnaires 1. Hx of Alzheimer Disease 2. Hx multiple strokes or other neurologic condition 3. Caregiver states the subject is unable to complete 4. MDs opinion * Inability to complete follow up visits due to transportation issues 1. No access to transportation (ie. does not have vehicle) 2. Live \> 2 hours from LLUH 3. Does not have financial means * Congenital anomalies 1. Bladder Exstrophy 2. Connective tissue disease 3. Neovaginal prolapse 4. Prolapse of sex change vagina * Chronic pelvic pain 1. \> 6 months of pelvic pain of undetermined origin 2. not cyclic pain (eg. period pain or dysmenorrhea) 3. Patient has comorbidities of CPP 4. Fibromyalgia 5. Interstitial cystitis 6. Vulvodynia * Contraindications to Mesh, 1. Opposition to the use mesh (ie. due to religious beliefs) 2. History of mesh complications in past * Pregnant or planning to become pregnant during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Pelvic Organ Prolapse Quantification (pop-q) to asses change post operatively3 month post operativePelvic organ prolapses are graded with the Pelvic Organ Prolapse Quantification (POP-Q) System.

Secondary

MeasureTime frameDescription
questionnaires PFDI-76 month post operativeSubject will fill out the PFDI-7 questionnaire
questionnaires PFIQ-206 month post operativeSubject will fill out the PFIQ-20 questionnaire
questionnaires PISQ-126 month post operativeSubject will fill out the PISQ-12 questionnaire
questionnaires PGI-I6 month post operativeSubject will fill out the PGI-I

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSam Siddighi

Loma Linda University Health Care

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026